• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

FDA Commissioner Scott Gottlieb to Step Down

Share:

March 12, 2019

Food and Drug Commissioner Scott Gottlieb has announced his resignation, effective in about a month. Dr. Gottlieb, a 46-year-old physician, former venture capitalist and drug consultant currently residing in Westport, Conn with his wife and three children stated he missed his family due to his weekly commute to Washington. D.C. Dr. Gottlieb had been subject to increasing pressure from some Republicans in Congress and others in the conservative moment for his strong stance against youth vaping and traditional cigarettes

“All of us at HHS are proud of the remarkable work Commissioner Gottlieb has done at the FDA. He has been an exemplary public health leader, aggressive advocate for American patients, and passionate promoter of innovation. I will personally miss working with Scott on the important goals we share, and I know that is true for so many other members of the HHS family.

Scott’s leadership inspired historic results from the FDA team, which delivered record approvals of both innovative treatments and affordable generic drugs while advancing important policies to confront opioid addiction, tobacco, and youth e-cigarette use, chronic disease, and more. The public health of our country is better off for the work Scott and the entire FDA team have done over the last two years,” said HHS Secretary Alex Azar in an issued public statement.

Date: March 13, 2019

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Coronavirus (COVID-19) Impact on Chloroquine Phosphate Market Status, Players, Types, Applications, and Forecast 2020-2026Coronavirus (COVID-19) Impact on Chloroquine Phosphate Market Status, Players, Types, Applications, and Forecast 2020-2026
  • Telehealth After COVID-19: What’s Next for the Healthcare Industry?Telehealth After COVID-19: What’s Next for the Healthcare Industry?
  • ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s DiseaseANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s Disease
  • GHO Capital Acquires Validant, a Leading Quality, Compliance and Regulatory Affairs Consulting Firm for Healthcare CompaniesGHO Capital Acquires Validant, a Leading Quality, Compliance and Regulatory Affairs Consulting Firm for Healthcare Companies
  • Sanofi Ups Immunology Game With $1.4 Billion Acquisition of KymabSanofi Ups Immunology Game With $1.4 Billion Acquisition of Kymab
  • WAVE Launches With $5.65M To Make Guided Meditation MainstreamWAVE Launches With $5.65M To Make Guided Meditation Mainstream
  • The Smart Care of the FutureThe Smart Care of the Future
  • Providence St. Joseph Health Acquires Epic Consulting Firm BluetreeProvidence St. Joseph Health Acquires Epic Consulting Firm Bluetree

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications